Tyra Biosciences to Participate at Upcoming Investor Conferences
Tyra Biosciences (NASDAQ: TYRA), a clinical-stage biotech company specializing in FGFR-targeted precision medicines, has announced its participation in three upcoming investor conferences. The company will attend the Bank of America Global Healthcare Conference (May 13-15) in Las Vegas, featuring a fireside chat on May 13 at 5:15 PM PT. Additionally, TYRA will participate in the Jefferies Global Healthcare Conference (June 3-5) and UBS Biotech 1x1 Symposium (June 24) in New York, both featuring one-on-one investor meetings. A webcast of the fireside chat will be accessible through TYRA's investor relations website.
Tyra Biosciences (NASDAQ: TYRA), una società biotech in fase clinica specializzata in farmaci di precisione mirati a FGFR, ha annunciato la sua partecipazione a tre prossimi convegni per investitori. La società sarà presente al Bank of America Global Healthcare Conference (13-15 maggio) a Las Vegas, con un incontro informale previsto per il 13 maggio alle 17:15 PT. Inoltre, TYRA parteciperà al Jefferies Global Healthcare Conference (3-5 giugno) e al UBS Biotech 1x1 Symposium (24 giugno) a New York, entrambi con incontri individuali con investitori. La registrazione dell'incontro informale sarà disponibile in streaming sul sito web delle relazioni con gli investitori di TYRA.
Tyra Biosciences (NASDAQ: TYRA), una empresa biotecnológica en etapa clínica especializada en medicamentos de precisión dirigidos a FGFR, ha anunciado su participación en tres próximas conferencias para inversores. La compañía asistirá a la Bank of America Global Healthcare Conference (13-15 de mayo) en Las Vegas, con una charla informal el 13 de mayo a las 5:15 PM PT. Además, TYRA participará en la Jefferies Global Healthcare Conference (3-5 de junio) y en el UBS Biotech 1x1 Symposium (24 de junio) en Nueva York, ambos con reuniones individuales con inversores. La transmisión en línea de la charla estará disponible en el sitio web de relaciones con inversores de TYRA.
Tyra Biosciences (NASDAQ: TYRA)는 FGFR 표적 정밀 의약품을 전문으로 하는 임상 단계의 바이오텍 회사로, 세 차례 예정된 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 5월 13일부터 15일까지 라스베이거스에서 열리는 Bank of America Global Healthcare Conference에 참석하며, 5월 13일 오후 5시 15분(태평양 시간)에 파이어사이드 채팅을 진행할 예정입니다. 또한 TYRA는 6월 3일부터 5일까지와 6월 24일 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 UBS Biotech 1x1 Symposium에 각각 참여하며, 모두 1:1 투자자 미팅을 포함합니다. 파이어사이드 채팅 웹캐스트는 TYRA 투자자 관계 웹사이트를 통해 시청할 수 있습니다.
Tyra Biosciences (NASDAQ : TYRA), une société biotechnologique en phase clinique spécialisée dans les médicaments de précision ciblant FGFR, a annoncé sa participation à trois prochaines conférences pour investisseurs. La société assistera à la Bank of America Global Healthcare Conference (du 13 au 15 mai) à Las Vegas, avec une discussion informelle prévue le 13 mai à 17h15 PT. De plus, TYRA participera à la Jefferies Global Healthcare Conference (du 3 au 5 juin) et au UBS Biotech 1x1 Symposium (le 24 juin) à New York, avec des réunions individuelles avec des investisseurs. Une webdiffusion de la discussion informelle sera accessible via le site des relations investisseurs de TYRA.
Tyra Biosciences (NASDAQ: TYRA), ein biotechnologisches Unternehmen in der klinischen Entwicklungsphase, das sich auf FGFR-gerichtete Präzisionsmedikamente spezialisiert hat, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an der Bank of America Global Healthcare Conference (13.-15. Mai) in Las Vegas teilnehmen und am 13. Mai um 17:15 Uhr PT ein Fireside-Chat abhalten. Darüber hinaus wird TYRA an der Jefferies Global Healthcare Conference (3.-5. Juni) und dem UBS Biotech 1x1 Symposium (24. Juni) in New York teilnehmen, beide mit Einzelgesprächen mit Investoren. Ein Webcast des Fireside-Chats wird über die Investor-Relations-Website von TYRA zugänglich sein.
- None.
- None.
- Bank of America Global Healthcare Conference, May 13-15, 2025
- Format: Fireside chat and one-on-one investor meetings
- Presentation Date/Time: Tuesday, May 13, 2025, at 5:15 PM PT
- Location:
Las Vegas, NV
- Jefferies Global Healthcare Conference, June 3-5, 2025
- Format: One-on-one investor meetings
- Location: New
York, NY
- UBS Biotech 1x1 Symposium, June 24, 2025
- Format: One-on-one investor meetings
- Location: New
York, NY
A live and archived webcast of the fireside chat will be available via the For Investors page on the Investor section of the TYRA website.
About Tyra Biosciences
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's expertise in FGFR biology has created a differentiated pipeline with three product candidates in clinical development in targeted oncology and genetically defined conditions. The Company's lead precision medicine stemming from SNÅP, TYRA-300, is a potential first-in-class selective FGFR3 inhibitor that is designed to avoid the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4, while being agnostic for the FGFR3 gatekeeper mutations. TYRA-300 is expected to be evaluated in three Phase 2 studies: SURF302 for IR NMIBC, BEACH301 for pediatric achondroplasia and SURF301 for metastatic urothelial cancer. TYRA is also developing TYRA-200, an oral, investigational, FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma, and TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers. TYRA is based in
For more information about our science, pipeline and people, please visit www.tyra.bio and engage with us on LinkedIn.
Contact:
Amy Conrad
aconrad@tyra.bio
View original content to download multimedia:https://www.prnewswire.com/news-releases/tyra-biosciences-to-participate-at-upcoming-investor-conferences-302452593.html
SOURCE Tyra Biosciences
FAQ
What investor conferences will TYRA stock attend in May and June 2025?
When is Tyra Biosciences' (TYRA) fireside chat at the Bank of America conference?
Where can investors watch Tyra Biosciences' (TYRA) conference presentation?
What is Tyra Biosciences' (TYRA) main business focus?
